Skip to main
SYK

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 27%
Buy 47%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is seen as a strong player in the medical technology industry, with a track record of successful M&A activities and a diverse portfolio of products in various healthcare sectors. Despite facing a cyber incident, the company's financial performance remains strong, with projected revenue growth and earnings above consensus. However, there are risks involved in increasing borrowing for future M&A opportunities, and recent acquisitions have not had a significant impact on top-line growth.

Bears say

Stryker is a medical technology company that operates under MedSurg and Neurotechnology, and Orthopaedics and Spine segments. However, with an outlook of -2.21%, despite their diversified revenue composition, consistent execution, and leading position in orthopedic robotics, the recent cyber incident and lower than expected financial performance are potential risks that may impact the company's growth and margins, leading to a negative outlook.

Stryker (SYK) has been analyzed by 15 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 47% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 15 analysts, Stryker (SYK) has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $396.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $396.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.